Search a product
INTERMEDIATE PRODUCT LIST
| Sr. No. | API Name | Intermediates | CAS Number |
| 1. | Azilsartan | Methyl 2-ethoxy-1-((2-(5-oxo-2,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate | 147403-52-9 |
| 2. | Azilsartan | 2-Ethoxy-1-[[2’[(hydroxyamino)iminomethyl][1,1’-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid Methyl Ester | 147403-65-4 |
| 3. | Ambroxol | 2-amino-3,5-dibromobenzaldehyde | 50910-55-9 |
| 4. | Chlorothalidone | 2-(4-chlorobenzoyl) benzoic acid | 85-56-3 |
| 5. | Chlorothalidone | 3(4-Chlorobenzoyl) Isoindolin-1-one | 2224-77-3 |
| 6. | Chlorothalidone | 2-Chloro-5-(3-oxoisoindolin-1-yl) benzene sulfonamide | 77-36-1 |
| 7. | Chlorothalidone | 4-(4-chlorophenyl)-1H-benzo[d][1,2]oxazin-1-one | 2224-83-1 |
| 8. | Azathioprine | N,N Dimethyloxalamide | 615-35-0 |
| 9. | Azathioprine | 5-Chloro-1-methyl-1H-imidazole nitrate salt | 4531-53-7 |
| 10. | Azathioprine | 5-chloro-1-methyl-nitroimidazole | 4897-25-0 |
| 11. | Closantal sodium | 3,5-diiodosalicylic acid | 133-91-5 |
| 12. | Dabigatran | Ethyl 3-(2-((4-cyanophenylamino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo (d) imidazole–5-carboxamido) propanoale | 211915-84-3 |
| 13. | Dabigatran | Ethyl 3-(2-((4-carbamimidoylphenylamino) methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d] imidazole-5-carboxamido) propanoale | 429658-95-7 |
INTERMEDIATE PRODUCT LIST
| Sr. No. | API Name | Intermediates | CAS Number |
| 14. | Dye Intermediate | Quinizarin (1,4-dihyroxy anthraquinone or 1,4- dihyroxyanthracene-9,10-dione) | 81-64-1 |
| 15. | Disperse Violet 28 | Disperse Violet 28 (DV) | 81-42-5 |
| 16. | Disperse Violet 26 | Disperse Violet 26 (DV) | 6408-72-6 |
| 17. | Gabapentin | Cyclohexane Diacatic Acid (CDA) | 4355-11-7 |
| 18. | Gabapentin | 1,1-Cyclohexane diacetic Acid Monoamide (CDMA) | 99189-60-3 |
| 19. | Ketoconazole | 1-Acetyl-4-hydroxy phenyl piperazine | 67915-02-0 |
| 20. | Itraconazole | Bis (2-chloroethyl)amine hydrochloride | 821-48-7 |
| 21. | Imatinib | N-(5-amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine | 152460-10-1 |
| 22. | Methotrexate | 4-formyl benzoic acid | 619-66-9 |
| 23. | Nitazoxanide | 2-Amino-5-nitrothiazole | 121-64-4 |
| 24. | Oxyclozanide | 3,5,6-Trichlorosalicylic acid (TCSA) | 40932-60-3 |
| 25. | Citalopram | 5-Carboxy phthalide | 4792-29-4 |
| 26. | Benserazide | 2,3,4-Trihydroxy benzaldeyol | 2144-08-03 |
| 27. | Minoxidil | 2,6-diamino-4-chloropyrimidine | 156-83-2 |
| 28. | – | Acetone Di-Carboxylic Acid | [542-05-2] |
| 28. | – | Isobutyramide | 563-83-7 |
| 29. | – | Chloro Acetaldehyde dimethyl Acetal | 97-97-2 |
| 33. | – | Bis (4-Aminophenl)terephthalate | 16926-73-1 |
| 34. | – | N-Methyl piperidine-2-ethanol | 533-15-3 |
| 35. | – | 2-Iodo-5-Bromo Benzoic Acid | 2174-00-1 |
| 36. | – | 2-chloro-6-Methoxy-3-Nitropyridine | 38533-61-8 |
| Sr. No. | API Name | Intermediates | CAS Number |
| 37. | – | 1,3,2,4-Bis-O-((4-Chlorophenyl)methylene)-D-glucitol | 82203-23-4 |
| 38. | – | 4-Nitrobenzoyl chloride | 122-04-3 |
| 39. | Sitagliptin | Sitagliptin ketoamide sodium salt | 1371636-28-0 |
| 40. | Iodinated disinfection, potent thyroid disrupting chemical | 2,4,6-Triiodophenol | 609-23-4 |
| 41. | – | Dimethyl malonate (DMM) | 108-59-8 |
| 42. | – | Dimethyl 3-aminoterephthalate | 5372-81-6 |
| 43. | – | 1,1-Sulfonyldiimidazole | 7189-69-7 |
| 44. | – | 2,2-Thiodiethanol | 111-48-8 |
| 45. | – | 4-Iodoanisole | 696-62-8 |
| 46. | Prasugrel | Methyl 4-Chlorobutyrate | 3153-37-5 |
| 47. | – | Sodium Iodide | 7681-82-5 |
| 48. | – | Potassium Iodide | 7681-11-0 |
| 49. | – | Di-Octyl Terephthalate (DOTP) | 6422-86-2 |
| 50. | – | 1-Ethyl-3-Methylimidatzolium ethyl sulfate | 342573-75-5 |
| 51. | – | Sodium Iodate | 7681-55-2 |
| 52. | – | Potassium iodate | 7758-05-6 |
| 53. | – | Ethyl Chloride | 75-00-3 |
| 54. | – | Isopropyl Formate | 625-55-8 |
| 55. | – | Lauramidopropylamine oxide | 61792-31-2 |
| 56. | – | Myristamidopropylamine oxide | 67806-10-4 |
| 57. | – | 2,3,5-Triiodobenzoic Acid | 88-82-4 |
| 58. | – | 2,2-Dimethyl-5-(3-thienyl)-1,3-dioxane-4,6-dione | 61857-83-8 |
| 59. | – | 1,3-Dichloro-5-(3,3,3-trifluoroprop-1-en-2-yl)benzene | 867425-22-4 |
| 60. | – | 4-Bromo-N-hydroxy-3-methylbenzene-1-carbonimidoyl chloride | 928782-65-4 |
| 61. | – | 2-Amino-N-(2,2,2-trifluoroethyl)acetamide | 359821-38-8 |
| 62. | – | 2-Ethylhexyl nitrate | 27247-96-7 |
| 63. | – | Amitrole | 61-82-5 |
| 64. | – | 5-Bromo -2-iodobenzoic acid | 21740-00-1 |
| 65. | – | Tri butyl phosphate (TBPO) | 126-73-8 |
| 66. | – | 2-[5-(2-hexyldecyl)-2-thienyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (HDT-BPM) | 1810044-61-1 |
| 67. | – | 2-Chloro-5-(3-Chloropropyl)3-ethyl sulfonyl pyridine (CLP) | 2505482-71-1 |
| 68. | – | 4-Formylimidazole | 3034-50-2 |
| 69. | – | 2-Amino-5-Chlorobenzophenone | 719-59-5 |
| 70. | – | 5,7-Dichloro-8-Hydroxy quinoline | 773-76-2 |
Disclaimer
We strive to provide our Contract Development and Manufacturing Organization (CDMO) services to a global audience. However, due to legal restrictions, we are currently unable to offer our services for products intended for commercialization in countries that recognize the patent(s) associated with the product.
This includes activities such as Development, Manufacturing, Testing, and Regulatory support
We apologize for any inconvenience this may cause. If you have any questions regarding patent restrictions or the availability of our services in your target market, please contact at [email protected].